SKAMo-2: the Real-life Test of Continuous Photoacoustic Signal by Neogly in Patients With Type I Diabetes

NAUnknownINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 6, 2023

Primary Completion Date

October 30, 2023

Study Completion Date

October 30, 2023

Conditions
Diabetes
Interventions
DEVICE

Non-invasive continuous monitoring device to record photoacoustic signal

"Neogly is in two parts, the measurement head, to be worn on the wrist and the power box, to be worn on the forearm or upper arm. The ribbon cable makes the connection between the two parts.~A handset is used to start/stop the device. The medical device record a continuous photoacoustic signal."

Trial Locations (1)

38043

RECRUITING

CHU Grenoble Alpes, Grenoble

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Eclypia

INDUSTRY

NCT06035367 - SKAMo-2: the Real-life Test of Continuous Photoacoustic Signal by Neogly in Patients With Type I Diabetes | Biotech Hunter | Biotech Hunter